Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans

Hartter, E., Svoboda, T., Ludvik, B., Schuller, M., Lell, B., Kuenburg, E., Brunnbauer, M., Woloszczuk, W. +1 more·1991·Diabetologia
DOI 10.1007/bf00404025

Cited by (191)

Items 101–191 of 191

  1. Amperometric immunoassay for the obesity biomarker amylin using a screen printed carbon electrode functionalized with an electropolymerized carboxylated polypyrrole
    Gonzalo Martínez García, Esther Sánchez‐Tirado, Araceli González-Cortés, Paloma Yáñez‐Sedeño, José Manuel Pingarrón · 2018 · Microchimica Acta
  2. Recent progress in the pharmacotherapy for obesity
    Lu, Jiale, Liu, Pengfei, Cai, Mengyang, Lv, Tongzhe, Zhang, Mengdi, Yin, Kaili, Cheng, Jie, Zhang, Guo · 2025 · European Journal of Pharmacology
  3. Safety, tolerability and pharmacokinetic characterisation of DACRA KBP‐042 in healthy male subjects
    Kim Henriksen, Karen Broekhuizen, Wadim M. I. de Boon, M.A. Karsdal, Asger Reinstrup Bihlet, Claus Christiansen, Marlous R. Dillingh, Marieke de Kam, Raj Kumar, Jacobus Burggraaf et al. · 2021 · British Journal of Clinical Pharmacology
  4. Salmon Calcitonin Attenuates Some Behavioural Responses to Nicotine in Male Mice
    Cajsa Aranäs, Jesper Vestlund, Sarah Witley, Christian E. Edvardsson, Aimilia Lydia Kalafateli, Elisabet Jerlhag · 2021 · Frontiers in Pharmacology
  5. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
    Bernhard H. Ludvik, Martin Clodi, Alexandra Kautzky‐Willer, Markus Schuller, Helmut Graf, E Hartter, Giovanni Pacini, Rudolf Prager · 1994 · Journal of Clinical Investigation
  6. Islet amyloid polypeptide (amylin) increases the renal excretion of calcium in the conscious dog
    Philip D.G. Miles, Leonard J. Deftos, A. R. Moossa, Jerrold M. Olefsky · 1994 · Calcified Tissue International
  7. New Incretin Combination Treatments under Investigation in Obesity and Metabolism: A Systematic Review
    Agni Kakouri, Georgia Kanti, Efthymios Kapantais, Alexandros D. Kokkinos, Leonidas Lanaras, Paul Farajian, Christos Galanakis, Georgios Georgantopoulos, Nikolaos Vlahos, George P. Mastorakos et al. · 2021 · Pharmaceuticals
  8. Fe–oxy adducts of heme–Aβ and heme–hIAPP complexes: intermediates in ROS generation
    Manas Seal, Soumya Mukherjee, Somdatta Ghosh Dey · 2016 · Metallomics
  9. Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes
    Xiaoxi Zhang, Yong-chao Qiao, Li Wan, Xia Zou, Yin-ling Chen, Jian Shen, Qinyuan Liao, Qiu-jin Zhang, Lan He, Hai‐Lu Zhao · 2017 · Immunologic Research
  10. Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus
    B. Nyholm, Birgitte Brock, L. Ørskov, Ole Schmitz · 2001 · Expert Opinion on Investigational Drugs
  11. Lack of effect of islet amyloid polypeptide on hepatic glucose output in the in situ-perfused rat liver
    Susumu Nishimura, Tokio Sanke, K Machida, Hiroto BESSHO, Tadashi Hanabusa, Kazuhiko Nakai, Kishio Nanjo · 1992 · Metabolism
  12. Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus
    Ralph A. DeFronzo, Lawrence J. Mandarino, Eleuterio Ferrannini · 2003 · Wiley eBooks
  13. Protective roles of adiponectin and molecular signatures of HNF4α and PPARα as downstream targets of adiponectin in pancreatic β cells
    Toshiharu Onodera, Dae-Seok Kim, Risheng Ye, May-Yun Wang, Shiuhwei Chen, Bianca C. Field, Leon G. Straub, Xue‐Nan Sun, Chao Li, Charlotte Lee et al. · 2023 · Molecular Metabolism
  14. Control of Postprandial Glucose Levels with Insulin in Type 2 Diabetes
    Thomas Blevins · 2011 · Postgraduate Medicine
  15. Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes
    Julie Pildal, Maria Lajer, Sara K. Hansen, Katrine Almind, Louise Ambye, K. Borch‐Johnsen, Bendix Carstensen, Torben F. Hansen, Oluf Borbye Pedersen · 2003 · Diabetic Medicine
  16. Non‐insulin dependent diabetes mellitus: defects in insulin secretion
    Bruce H. R. Wolffenbuttel, Timon W. van Haeften · 1993 · European Journal of Clinical Investigation
  17. Plasma Concentrations of Islet Amyloid Polypeptide After Glucagon Administration in Type 2 Diabetic Patients and Non‐diabetic Subjects
    Brigit C. van Jaarsveld, W. H. L. Hackeng, Cornelis J.M. Lips, D.W. Erkelens · 1993 · Diabetic Medicine
  18. Intraislet somatostatin inhibits insulin (via a subtype-2 somatostatin receptor) but not islet amyloid polypeptide secretion in the isolated perfused human pancreas
    Azmi Atiya, Stefan Moldovan, Thomas Edward Adrian, David H. Coy, John Henry Walsh, Francis Charles Brunicardi · 1997 · Journal of Gastrointestinal Surgery
  19. No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes
    Bo Åhrén, M. Gutniak · 1997 · European Journal of Endocrinology
  20. The Use of Chromogranin, Synaptophysin and Islet Amyloid Polypeptide as Markers for Neuroendocrine Tumours
    Mats Stridsberg · 1995 · Upsala Journal of Medical Sciences
  21. Managing Highly Insulin-Resistant Diabetes Mellitus: Weight Loss Approaches and Medical Management
    Aparna Brown, Megha Desai, Deepa Taneja, Lisa R. Tannock · 2010 · Postgraduate Medicine
  22. Amylin immunoreactivity in the rat trachea and characterization of the interaction of amylin and somatostatin on airway mucus secretion
    Ulrich Wagner, Dirk Bredenbröker, Peter Josef Barth, Hans Christoph Fehmann, Peter von Wichert · 1995 · Research in Experimental Medicine
  23. Glucose tolerance in Japanese subjects with S20G mutation of the amylin gene
    Kentaro Yamada, Xiaohong Yuan, Satomi Ishiyama-Shigemoto, K. Nonaka · 1998 · Diabetologia
  24. Central nervous system pathways targeted by amylin in the regulation of food intake
    Mohammed K. Hankir, Christelle Le Foll · 2024 · Biochimie
  25. First-Phase Insulin and Amylin after Bariatric Surgery: A Prospective Randomized Trial on Patients with Insulin Resistance or Diabetes after Gastric Bypass or Sleeve Gastrectomy
    Rahel Nussbaumer, Anne Christin Meyer‐Gerspach, Ralph Peterli, Thomas T. A. Peters, Christoph Beglinger, Sonja Chiappetta, Jürgen Drewe, Bettina Karin Wölnerhanssen · 2020 · Obesity Facts
  26. Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors
    Noah B.C. Piper, Emily A. Whitfield, Gregory D. Stewart, Xiaomeng Xu, Sebastian G. B. Furness · 2022 · Biochemical Pharmacology
  27. Reverse engineering an amyloid aggregation pathway with dimensional analysis and scaling
    J. Bailey, K. Potter, B. Verchere, L. Edelstein-Keshet, D. Coombs · 2011 · Physical Biology
  28. Diabetes Treatment, Part 3: Insulin and Incretins
    Michael J. Fowler · 2008 · Clinical Diabetes
  29. The Specificity of Amylin for the Diagnosis of Pancreatic Adenocarcinoma
    Randall E. Brand, Xianzhong Ding, Christine M. Young, Thomas Edward Adrian · 2002 · International Journal of Gastrointestinal Cancer
  30. Whole-Body Autoradiography of 123 I-Labelled Islet Amyloid Polypeptide (IAPP) Accumulation in the lung parenchyma and in the villi of the intestinal mucosa in rats
    Mats Stridsberg, Hans Tjälve, Erik Wilander · 1993 · Acta Oncologica
  31. Human IAPP is a contributor to painful diabetic peripheral neuropathy
    Mohammed M. H. Albariqi, S. Versteeg, E. M. Brakkee, J. Coert, Barend O. W. Elenbaas, J. Prado, C. Hack, J. Höppener, N. Eijkelkamp · 2021 · bioRxiv
  32. Tat‐biliverdin reductase A protects INS‐1 cells from human islet amyloid polypeptide‐induced cytotoxicity by alleviating oxidative stress and ER stress
    Su Jin Lee, Hyung Kyung Kang, Won Sik Eum, Jinseu Park, Soo Young Choi, Hyeok Yil Kwon · 2017 · Cell Biology International
  33. Epidemiología genética sobre las teorías causales y la patogénesis de la diabetes mellitus tipo 2
    Carlos Jonnathan Castro‐Juárez, Sergio Alberto Ramirez-Garcia, Nemesio Villa‐Ruano, Diana García‐Cruz · 2017 · Gaceta Médica de México
  34. Islet Amyloid Polypeptide: Does it Play a Pathophysiological Role in the Development of Diabetes?
    W. M. Bennet, David M. Smith, Stephen Robert Bloom · 1994 · Diabetic Medicine
  35. Section Review Oncologic, Endocrine & Metabolic: The amylin, CGRP and calcitonin family of peptides
    Nigel R. A. Beeley, Kathryn S. Prickett · 1996 · Expert Opinion on Therapeutic Patents
  36. Insulin treatment improves relative hypersecretion of amylin to insulin in rats with non-insulin-dependent diabetes mellitus induced by neonatal streptozocin injection
    Shinsuke Hiramatsu, Kaoru Inoue, Yasuhiro Sako, Fumio Umeda, Hajime Nawata · 1994 · Metabolism
  37. Preliminary examination of insulin and amylin levels in women with purging disorder
    Calyn B. Maske, Diana L. Williams, Pamela K. Keel · 2020 · International Journal of Eating Disorders
  38. Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus
    Rodolfo Guardado‐Mendoza, Alberto O. Chávez, Lilia M. Jiménez-Ceja, ANDREA A. HANSIS-DIARTE, Ralph Anthony DeFronzo, Franco B. Folli, Devjit Tripathy · 2016 · Acta Diabetologica
  39. Cloning and expression of human islet amyloid polypeptide in cultured cells
    Susinjan Bhattacharya, J. Naveena Lavanya Latha, R. Kumresan, Shashi Sekhar Singh · 2007 · Biochemical and Biophysical Research Communications
  40. Islet Amyloid Polypeptide—Hen or EGG in Type 2 Diabetes Pathogenesis?
    Christer Betsholtz, Lars Christmanson, Samuel Gebré‐Medhin, Per Westermark · 1993 · Acta Oncologica
  41. Pancreatic Islet Amyloid and Diabetes
    Anne Clark, J. H. Moffitt · 2007 · Springer eBooks
  42. Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes
    Abdülhalim Şenyiğit, Ömür Tabak, Timur Orhanoğlu, Aytaç Karadaǧ, Serdal Uğurlu, Hafize Uzun, Dildar Konukoğlu · 2017 · Clinical and investigative medicine
  43. Amylin, Amyloid and Age-Related Disease
    Garth J. S. Cooper, Cynthia A. Tse · 1996 · Drugs & Aging
  44. High plasma amylin/islet amyloid polypeptide levels in patients with residual medullary thyroid carcinoma after total thyroidectomy
    Maria K Alevizaki, S I Grigorakis, Sofia Tseleni‐Balafouta, Calliope C. Alevizaki, George Philippou, E. Anastasiou, Athanassios Souvatzoglou · 2001 · European Journal of Endocrinology
  45. Kill two birds with one stone: making multi-transgenic pre-diabetes mouse models through insulin resistance and pancreatic apoptosis pathogenesis
    Siyuan Kong, Jinxue Ruan, Kaiyi Zhang, Bingjun Hu, Yuzhu Cheng, Yubo Zhang, Shulin Yang, Kui Li · 2018 · PeerJ
  46. Metabolic Disturbances in Diabetes
    Adrian V Vella, Robert A. Rizza · 2010 · Wiley eBooks
  47. Noninsulin Therapies in Management of Type 1 Diabetes
    Zeb Ijaz Saeed, Jayachidambaram Ambalavanan, Melanie Natasha Rayan, Palak Patadia, Viral N. Shah · 2025 · Endocrine Practice
  48. Innovative Glucagon-based Therapies for Obesity
    Kibret Enyew Belay, Rebil Heiru Jemal, Aloys Tuyizere · 2024 · Journal of the Endocrine Society
  49. Neuroendocrine Control of Energy Stores
    Roger D. Cone, Joel Keith Elmquist · 2011 · Elsevier eBooks
  50. Pathogenesis of Type 2 Diabetes
    Kenneth J. Cusi, Ralph A. DeFronzo · 2001 · Comprehensive physiology
  51. Islet Amyloid Polypeptide (IAPP) and Insulin Secretion
    Peter C. Butler, Norman L. Eberhardt, Timothy D. O’Brien · 1994 · Humana Press eBooks
  52. Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review
    Evangelia Tzeravini, Stamatia Simati, Ioanna A. Anastasiou, Μaria Dalamaga, Alexander D. Kokkinos · 2026 · Current Obesity Reports
  53. Non-Insulin Treatments for Diabetes
    Eugenio Angueira-Serrano · 2013 · American Journal of Therapeutics
  54. Amylin and Related Proteins: Physiology and Pathophysiology
    Garth J. S. Cooper · 2001 · Comprehensive physiology
  55. Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine
    Kyle D. Medak, Stewart Jeromson, Annalaura Bellucci, Meagan Arbeau, David Charles Wright · 2023 · iScience
  56. Investigation of supramolecular structures in various aqueous solutions of an amyloid forming peptide using small-angle X-ray scattering
    Ellen Brunzell, Kalle Sigfridsson, Lars Gedda, Katarina Edwards, Magnus Bergström · 2024 · Soft Matter
  57. Pramlintide: profile of an amylin analog
    Harold E. Lebovitz · 2012 · Expert Review of Endocrinology & Metabolism
  58. Development and Characterization of Monoclonal Antibodies Specific for Amylin
    J Phelps, E. Blase, J. Koda · 1996 · Hybridoma
  59. Pramlintide in Pediatric Type 1 Diabetes
    Ilene Fennoy · 2009 · The Journal of Pediatrics
  60. Metabolic Disturbances in Diabetes
    Adrian V Vella, Robert A. Rizza · 2016 · Wiley eBooks
  61. Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors
    Yi-min Gu, Qingning Yuan, Xin Li, He Qian, H. Eric Xu, Lihua Zhao · 2025 · Acta Pharmacologica Sinica
  62. Decreased islet amyloid polypeptide staining in the islets of insulinoma patients
    Chisaki Ishibashi, Sho Yoneda, Yukari Fujita, Shingo Fujita, Kento Mitsushio, Harutoshi Ozawa, Megu Yamaguchi Baden, Takao Nammo, Junji Kozawa, Hidetoshi Eguchi et al. · 2024 · Islets
  63. Glycosaminoglycans, Proteoglycans, and Conformational Disorders
    Gregory J. Cole, I.-Hsuan Liu · 2007 · Springer eBooks
  64. Biochemical Alterations Induced by Amylin in Wistar Rats
    M. Soliman, Z. Ibrahim · 2013 · American Journal of Pharmacology and Toxicology
  65. Amylin and Calcitonin Gene-Related Peptide
    Dorit Naot, Ian R. Reid, Jill Cornish · 2008 · Elsevier eBooks
  66. Neuroendocrine Control of Energy Stores
    Roger D. Cone, Joel Keith Elmquist · 2016 · Elsevier eBooks
  67. Therapeutic Potential of Human Amylin Analogues in Diabetes Mellitus
    Garth J. S. Cooper · 1998 · BioDrugs
  68. Lipid Dynamics in the Amyloid Cascade Hypothesis: Evaluating the Biological Relevance of In Vitro Models
    Sofia Serravalle, Fabio Lolicato, Carmelo Tempra, Martina Pannuzzo, Michele F. M. Sciacca, Danilo Milardi, Carmelo La Rosa · 2026 · ChemBioChem
  69. Diabetes Treatment: Insulin and Incretins
    Michael J. Fowler · 2010 · Clinical Diabetes
  70. Insulin therapy: a century of continuing progress
    Geremia B. Bolli, Carmine Giuseppe Fanelli, Paola Lucidi, Francesca Porcellati · 2023 · Elsevier eBooks
  71. Rodent islet amyloid polypeptide (IAPP) selectively enhances GABAA receptor-mediated neuronal inhibition in mouse ventral but not dorsal hippocampal dentate gyrus granule cells
    Olga Netsyk, Sergiy V. Korol, Gunilla Torstensdotter Westermark, Bryndis Birnir, Zhe Jin · 2025 · Frontiers in Cellular Neuroscience
  72. Sounding board: diabetes mellitus in the elderly: a truly heterogeneous entity?
    Sanjay Ratnakant, Matthew E. Ochs, Solomon S. Solomon · 2003 · Diabetes Obesity and Metabolism
  73. Studies of Aggregation Pathways for Amyloidogenic Peptides by Dielectric Relaxation Spectroscopy
    D. J. Barry · 2013 · Digital WPI
  74. Radioimmunoassay of regulatory peptides in the presence of acetonitrile: marked improvement of cholecystokinin assays
    Margery K. Herrington, Robert A. Cina, Thomas Edward Adrian · 1998 · Regulatory Peptides
  75. Intensive Therapy Preserves Insulin Secretion
    Zeno L. Charles-Marcel · 1998 · Annals of Internal Medicine
  76. Amilina: del estudio molecular a las acciones fisiológicas
    I. Rojas, Anna Novials · 2001 · Endocrinología y Nutrición
  77. Studies of neuropeptides in pancreatic beta cell function with special emphasis on islet amyloid polypeptide (IAPP).
    Ella Karlsson · 2000 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  78. Perfil de expressão de genes modulados pela amilina em ilhotas pancreáticas de rato
    Leonardo Sokolnik de Oliveira · 2009 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  79. Phenomenological modeling of the nucleated polymerization of human islet amyloid polypeptide : a combined experimental and theoretical approach
    James A. Bailey · 2008 · cIRcle (University of British Columbia)
  80. Genetic epidemiology on casual theories and pathogenesis of type 2 diabetes mellitus
    Carlos Jonnathan Castro‐Juárez, Sergio Alberto Ramirez-Garcia, Nemesio Villa‐Ruano, Diana García‐Cruz · 2018 · Gaceta Médica de México
  81. Amylin and Calcitonin Gene-Related Peptide
    Ian R. Reid, Jill Cornish · 2002 · Elsevier eBooks
  82. Late Pathomorphological Features of the Endocrine Pancreas in Patients With Type 2 Diabetes Mellitus
    Irina Tomova, George S Stoyanov, Deyan L. Dzhenkov, Lilyana Petkova · 2020 · Cureus
  83. Amylin, Amyloid and Age-Related Disease
    Garth · 2012
  84. Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus
    Xiaoya ZhengWei, RenSuhua Zhang, Ping YangJun · 2010
  85. インスリン非依存型糖尿病患者および境界型耐糖能異常者におけるすいラ島アミロイド蛋白（ＩＡＰＰ／Ａｍｙｌｉｎ）の血中動態（第２報）
    中野 好夫, Tokio Sanke, 澳 親人, 弘樹 慈幸, 輝志男 南條 · 1995 · 糖尿病
  86. Peer Review #1 of "Kill two birds with one stone: making multi-transgenic pre-diabetes mouse models through insulin resistance and pancreatic apoptosis pathogenesis (v0.1)"
    2018 · PeerJ
  87. Peer Review #1 of "Kill two birds with one stone: making multi-transgenic pre-diabetes mouse models through insulin resistance and pancreatic apoptosis pathogenesis (v0.2)"
    2018 · PeerJ
  88. Peer Review #2 of "Kill two birds with one stone: making multi-transgenic pre-diabetes mouse models through insulin resistance and pancreatic apoptosis pathogenesis (v0.2)"
    2018 · PeerJ
  89. Peer Review #2 of "Kill two birds with one stone: making multi-transgenic pre-diabetes mouse models through insulin resistance and pancreatic apoptosis pathogenesis (v0.1)"
    2018 · PeerJ
  90. Pathogenesis of Type 2 Diabetes
    Kenneth J. Cusi, Ralph Anthony DeFronzo · 2001 · Comprehensive physiology
  91. Amylin and Related Proteins: Physiology and Pathophysiology
    Garth J. S. Cooper · 2001 · Comprehensive physiology